The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 12, 2023

Filed:

Dec. 21, 2018
Applicants:

Nantomics, Llc, Culver City, CA (US);

Nantbio, Inc., Culver City, CA (US);

Nant Holdings Ip, Llc, Culver City, CA (US);

Inventors:

Kevin B. Givechian, Culver City, CA (US);

Kamil A. Wnuk, Culver City, CA (US);

Chad Garner, Culver City, CA (US);

Stephen Charles Benz, Culver City, CA (US);

Hermes J. Garban, Culver City, CA (US);

Shahrooz Rabizadeh, Culver City, CA (US);

Kayvan Niazi, Culver City, CA (US);

Patrick Soon-Shiong, Culver City, CA (US);

Assignees:

Nantomics LLC, Culver City, CA (US);

NantBio, Inc., Culver City, CA (US);

Nant Holdings IP, LLC, Culver City, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G16B 25/10 (2019.01); C12Q 1/6886 (2018.01);
U.S. Cl.
CPC ...
G16B 25/10 (2019.02); C12Q 1/6886 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01);
Abstract

An immune gene expression signature is associated with favorable clinical features in Treg-enriched tumor samples and can be used to predict immunogenicity of a tumor, overall survival, and/or chemosensitivity.


Find Patent Forward Citations

Loading…